Imagine a world where doctors are able to target and remove infected cells, pathogens, toxins, or even viruses directly from a patient's bloodstream. At MediSieve we are working towards bringing this dream into a reality. Our Magnetic Blood Filtration System is a device-therapeutic combination that filters harmful substances from the bloodstream using magnetic forces.

If you've always dreamt of making a global impact, MediSieve is the place to be! The platform nature of our technology enables us to make a difference in treating humanity's most serious diseases, with the first product targeting hyperinflammation in conditions such as COVID-19, Sepsis, and Cytokine Release Syndrome.

Join Our Team As

Latest News

MediSieve Announces First Volunteer Successfully Enrolled in Phase 1 Clinical Study

MediSieve Announces First Volunteer Successfully Enrolled in Phase 1 Clinical Study
July 08, 2022

Radboud University Medical Center is Conducting Safety Evaluation of MediSieve’s Magnetic Haemofiltration System for the Treatment of Acute Hyperinflammation.
MediSieve at Industry Events In June 2022

MediSieve at Industry Events In June 2022
June 29, 2022

MediSieve, a London based biotech startup, has been busy presenting and demonstrating its technology at industry events as well as connecting with fellow scientists throughout June.